Strategic partnerships NCCS actively engages with industry partners and research hubs (e.g., Hitachi, Lucence, A*STAR, NYP) to advance treatment modalities (Proton Beam Therapy) and translational research, presenting opportunities for co-development, sponsored programs, and technology integrations.

Proton therapy expansion The launch and expansion of Proton Beam Therapy at NCCS, including the Goh Cheng Liang Proton Therapy Centre, signals a strong capacity for proton treatment services and potential demand for related equipment, facility management, and data analytics to optimize patient outcomes.

Clinical research hub Active collaboration on GENERATIONAL cancer profiling tests and translational research initiatives (UNITED 2.0, partnerships with Lucence) create avenues for diagnostics, sequencing, AI-driven patient stratification, and CRO or technology licensing opportunities.

Digital patient experience Recent VR procedure-prep initiatives for pediatric patients indicate a commitment to patient-centric, innovative care delivery; potential for partnerships in medical VR, simulation software, patient education platforms, and telemedicine-enabled workflows.

Growth and capability With a sizable clinical and research footprint, ongoing capacity expansion, and international collaboration, NCCS represents a multi-faceted sales target for healthcare IT, clinical equipment, training services, and sustaining engineering to support advanced oncology care.